Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China · Delayed Price · Currency is CNY 22.60
-0.16 (-0.70%)
Jun 2, 2026, 3:00 PM CST
SHA:605177 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -110.67 | -82.39 | -100.66 | 121.25 | 104.43 | 68.49 |
Depreciation & Amortization | 155.32 | 155.32 | 136.58 | 112.42 | 94.25 | 69.53 |
Other Amortization | 4.43 | 4.43 | 3.48 | 1.96 | 1.41 | 0.92 |
Loss (Gain) From Sale of Assets | 0.39 | 0.39 | 3.13 | 2.25 | 1.05 | 0.61 |
Asset Writedown & Restructuring Costs | 4.53 | 4.53 | 23.8 | 3.44 | 4.49 | 3.44 |
Loss (Gain) From Sale of Investments | -2.93 | -2.93 | -3.94 | -7.03 | -7.85 | -7.42 |
Provision & Write-off of Bad Debts | -0.12 | -0.12 | 0.86 | 2.72 | 1.31 | -1.01 |
Other Operating Activities | 253.95 | 59.01 | 132.46 | 11.38 | 0.2 | 7.18 |
Change in Accounts Receivable | -174.46 | -174.46 | -270.56 | -54.33 | -246.17 | -12.58 |
Change in Inventory | 133.27 | 133.27 | -240.69 | -148.97 | -63.04 | -158.47 |
Change in Accounts Payable | -361.36 | -361.36 | 139.16 | -138.81 | 45.44 | 2.71 |
Change in Other Net Operating Assets | 13.54 | 13.54 | 40.49 | 9.49 | -4.13 | 6.76 |
Operating Cash Flow | -102.19 | -268.86 | -156.55 | -84.06 | -70.35 | -23.6 |
Capital Expenditures | -48.65 | -74.26 | -211.61 | -227.47 | -87.82 | -121.97 |
Sale of Property, Plant & Equipment | 2.39 | 1.44 | 1.57 | 2.29 | 2.32 | 5.37 |
Investment in Securities | 142.63 | -66.82 | 96.18 | -110.08 | 20 | -220 |
Other Investing Activities | 3.81 | 3.32 | 23.7 | 0.7 | 1.52 | 2.4 |
Investing Cash Flow | 100.18 | -136.31 | -90.16 | -334.57 | -63.98 | -334.2 |
Short-Term Debt Issued | - | 69.67 | 98.31 | - | - | - |
Long-Term Debt Issued | - | 358.98 | 204.4 | 172.5 | 27 | 2 |
Total Debt Issued | 278.67 | 428.65 | 302.71 | 172.5 | 27 | 2 |
Short-Term Debt Repaid | - | -100 | -50 | -85 | - | - |
Long-Term Debt Repaid | - | -159.93 | -174.79 | -135.09 | -6.38 | -12.54 |
Total Debt Repaid | -199.73 | -259.93 | -224.79 | -220.09 | -6.38 | -12.54 |
Net Debt Issued (Repaid) | 78.94 | 168.72 | 77.93 | -47.59 | 20.62 | -10.54 |
Issuance of Common Stock | - | - | 20.55 | 683.49 | - | - |
Repurchase of Common Stock | -0.27 | -0.27 | -25 | -30 | - | - |
Common Dividends Paid | -9.5 | -8.61 | -41.6 | -36.25 | -23.36 | -39.04 |
Other Financing Activities | -0.04 | -0.16 | -0.34 | 47.37 | 91.23 | -4.53 |
Financing Cash Flow | 69.14 | 159.68 | 31.54 | 617.02 | 88.48 | -54.12 |
Foreign Exchange Rate Adjustments | 0.12 | 1.13 | 2.54 | 0.99 | 0.22 | -0.29 |
Net Cash Flow | 67.25 | -244.36 | -212.63 | 199.38 | -45.63 | -412.21 |
Free Cash Flow | -150.84 | -343.11 | -368.16 | -311.53 | -158.17 | -145.57 |
Free Cash Flow Margin | -14.88% | -36.49% | -30.73% | -22.97% | -13.41% | -20.44% |
Free Cash Flow Per Share | -1.32 | -2.00 | -2.52 | -2.49 | -1.39 | -1.27 |
Cash Interest Paid | - | - | - | - | 1.51 | - |
Cash Income Tax Paid | - | -23.37 | -3.13 | 19.37 | -12.47 | -7.63 |
Levered Free Cash Flow | 196.37 | -111.19 | -3.06 | -143.19 | -6.44 | -57.01 |
Unlevered Free Cash Flow | 211.71 | -100.35 | -1.79 | -140.94 | -5.91 | -56.87 |
Change in Working Capital | -407.09 | -407.09 | -352.25 | -332.45 | -269.64 | -165.34 |